# Federal Register
1 - 57:12717 - Occupational Exposure to Bloodborne Pathogens, OMB approval of Information Collection Requirements
# Regulations
1 1910.1030(c)(1)(v) - Bloodborne pathogens.
# Standard Interpretations
1 - 1910.1030(c)(1)(v) - Applicability of the Bloodborne Pathogens standard during transection of the umbilical cord.
2 - 1910.1030(c)(1)(v) - OSHA's position on the use of Novartis' Fluvirin device.
3 - 1910.1030(c)(1)(v) - Requirements for safety-engineered sharps for stockpiled pandemic influenza vaccines and pre-filled syringes.
4 - 1910.1030(c)(1)(v) - Limiting factors for implementing the use of engineering controls, i.e., safety scalpels, under the Bloodborne Pathogens standard.
5 - 1910.1030(c)(1)(v) - Bloodborne Pathogens Standard application to bifurcated needles; acceptability and appropriateness of safety bifurcated needles.
6 - 1910.1030(c)(1)(v) - Clarification from OSHA regarding the use of the NeedleguardTM in a hospital environment.
7 - 1910.1030(c)(1)(v) - Engineering control requirements for allergy and immunization injections.
8 - 1910.1030(c)(1)(v) - Needlestick Safety and Prevention Act and the requirement to include safety-engineered sharps devices in pre-packaged surgical kits or trays.
9 - 1910.1030(c)(1)(v) - Safer medical devices must be selected based on employee feedback and device effectiveness, not Group Purchasing Organizations.